- Home
- PCLA vs ALGS Comparison
PCLA vs ALGS Comparison
Compare PCLA & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCLA
- ALGS
- Stock Information
- Founded
- PCLA 2008
- ALGS 2018
- Country
- PCLA Japan
- ALGS United States
- Employees
- PCLA N/A
- ALGS N/A
- Industry
- PCLA Building Products
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- PCLA Consumer Discretionary
- ALGS Health Care
- Exchange
- PCLA Nasdaq
- ALGS Nasdaq
- Market Cap
- PCLA 32.3M
- ALGS 36.0M
- IPO Year
- PCLA 2025
- ALGS 2020
- Fundamental
- Price
- PCLA $0.87
- ALGS $5.95
- Analyst Decision
- PCLA
- ALGS Strong Buy
- Analyst Count
- PCLA 0
- ALGS 1
- Target Price
- PCLA N/A
- ALGS $70.00
- AVG Volume (30 Days)
- PCLA 323.4K
- ALGS 149.9K
- Earning Date
- PCLA 01-01-0001
- ALGS 05-06-2025
- Dividend Yield
- PCLA N/A
- ALGS N/A
- EPS Growth
- PCLA N/A
- ALGS N/A
- EPS
- PCLA N/A
- ALGS N/A
- Revenue
- PCLA $5,475,228.00
- ALGS $3,270,000.00
- Revenue This Year
- PCLA N/A
- ALGS N/A
- Revenue Next Year
- PCLA N/A
- ALGS N/A
- P/E Ratio
- PCLA N/A
- ALGS N/A
- Revenue Growth
- PCLA 40.19
- ALGS N/A
- 52 Week Low
- PCLA $0.37
- ALGS $3.76
- 52 Week High
- PCLA $9.80
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- PCLA N/A
- ALGS 45.36
- Support Level
- PCLA N/A
- ALGS $5.47
- Resistance Level
- PCLA N/A
- ALGS $6.12
- Average True Range (ATR)
- PCLA 0.00
- ALGS 0.51
- MACD
- PCLA 0.00
- ALGS 0.07
- Stochastic Oscillator
- PCLA 0.00
- ALGS 23.48
About PCLA PicoCELA Inc. American Depositary Shares
PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.